These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 37502021)
1. Treatment setting among individuals with opioid use and criminal legal involvement, housing instability, or Medicaid insurance, 2015-2021. Shearer RD; Howell BA; Khatri UG; Winkelman TNA Drug Alcohol Depend Rep; 2023 Sep; 8():100179. PubMed ID: 37502021 [TBL] [Abstract][Full Text] [Related]
2. Latine perspectives on the impact of family, perceptions of medication, health systems, incarceration, and housing on accessing opioid agonist therapy: A thematic analysis. Ascunce Gonzalez K; Swartz N; Linares MA; Gelpí-Acosta C; Chatterjee A J Subst Use Addict Treat; 2024 Aug; 167():209491. PubMed ID: 39179210 [TBL] [Abstract][Full Text] [Related]
3. Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation. Johnson NL; Choi S; Herrera CN J Subst Abuse Treat; 2022 Feb; 133():108533. PubMed ID: 34218991 [TBL] [Abstract][Full Text] [Related]
4. Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study. Hartung DM; Markwardt S; Johnston K; Geddes J; Baker R; Leichtling G; Hildebran C; Chan B; Cook RR; McCarty D; Ghitza U; Korthuis PT Addict Sci Clin Pract; 2022 Aug; 17(1):45. PubMed ID: 35986384 [TBL] [Abstract][Full Text] [Related]
5. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder. Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615 [TBL] [Abstract][Full Text] [Related]
6. Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use. Hollander MAG; Chang CH; Douaihy AB; Hulsey E; Donohue JM Drug Alcohol Depend; 2021 Oct; 227():108927. PubMed ID: 34358766 [TBL] [Abstract][Full Text] [Related]
7. National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness. Han BH; Doran KM; Krawczyk N J Subst Abuse Treat; 2022 Jan; 132():108504. PubMed ID: 34102461 [TBL] [Abstract][Full Text] [Related]
8. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness. Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306 [TBL] [Abstract][Full Text] [Related]
9. State level variation in substance use treatment admissions among criminal legal-referred individuals. Shearer RD; Winkelman TNA; Khatri UG Drug Alcohol Depend; 2022 Nov; 240():109651. PubMed ID: 36228467 [TBL] [Abstract][Full Text] [Related]
10. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic. Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198 [TBL] [Abstract][Full Text] [Related]
11. Adolescent-Serving Addiction Treatment Facilities in the United States and the Availability of Medications for Opioid Use Disorder. Alinsky RH; Hadland SE; Matson PA; Cerda M; Saloner B J Adolesc Health; 2020 Oct; 67(4):542-549. PubMed ID: 32336560 [TBL] [Abstract][Full Text] [Related]
12. Cross sectional analysis of an addiction consultation service, substance co-use patterns, and receipt of medications for opioid use disorder during hospitalization. Shearer RD; Bart G; Beebe TJ; Virnig BA; Shippee ND; Winkelman TNA J Subst Use Addict Treat; 2024 Sep; 167():209505. PubMed ID: 39241929 [TBL] [Abstract][Full Text] [Related]
13. A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System. Grella CE; Ostile E; Scott CK; Dennis M; Carnavale J Int J Drug Policy; 2020 Jul; 81():102768. PubMed ID: 32446130 [TBL] [Abstract][Full Text] [Related]
14. Estimating the impact on initiating medications for opioid use disorder of state policies expanding Medicaid and prohibiting substance use during pregnancy. Choi S; Stein MD; Raifman J; Rosenbloom D; Clark JA Drug Alcohol Depend; 2021 Dec; 229(Pt A):109162. PubMed ID: 34768053 [TBL] [Abstract][Full Text] [Related]
15. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings. Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162 [TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use. Xu KY; Mintz CM; Presnall N; Bierut LJ; Grucza RA JAMA Netw Open; 2022 May; 5(5):e2211363. PubMed ID: 35536575 [TBL] [Abstract][Full Text] [Related]
17. Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C. Andraka-Christou B; Saloner B; Gordon AJ; Totaram R; Randall-Kosich O; Golan M; Stein BD Am J Drug Alcohol Abuse; 2022 Jul; 48(4):492-503. PubMed ID: 35772010 [No Abstract] [Full Text] [Related]
18. Simulating the effects of medicaid expansion on the opioid epidemic in North Carolina. Berghammer A; Adams JW; Khan S; Bobashev G Drug Alcohol Depend Rep; 2024 Sep; 12():100262. PubMed ID: 39139778 [TBL] [Abstract][Full Text] [Related]
19. Dental care utilization in Massachusetts before and after initiation of medication for opioid use disorder: A cross-sectional study of a state all-payer claims database. Simon L; Choudhary A; Ticku S; Barrow J; Tobey M J Public Health Dent; 2022 Sep; 82(4):461-467. PubMed ID: 34816438 [TBL] [Abstract][Full Text] [Related]
20. Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study. Morse E; Binswanger IA; Taylor E; Gray C; Stimmel M; Timko C; Harris AHS; Smelson D; Finlay AK J Subst Abuse Treat; 2021 Oct; 129():108353. PubMed ID: 34080564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]